4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

695.00p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,250.00
  • 52 Week Low: 680.00
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 269
  • Market Cap: £107.99m

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,119,688 £7,781,832
Amy Walker 44,016 £305,911
Hansjörg Plaggemars 6,667 £46,336

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £35,582,214
DELPHI Unternehmensberatung AG 5,119,743 £35,582,214
4bb AG 5,115,852 £35,555,171
M&G Plc 4,627,741 £32,162,800
Elevage Medical Technologies Holdings 4,627,741 £32,162,800
Deutsche Balaton AG 4,432,637 £30,806,827
2invest AG 2,229,083 £15,492,127
Sparta AG 1,351,718 £9,394,440
Latonba AG 778,891 £5,413,292
Franciscus De Busschere 537,255 £3,733,922

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 695.00p
Change Today -17.50p
% Change -2.46 %
52 Week High 1,250.00
52 Week Low 680.00
Volume 269
Shares Issued 15.54m
Market Cap £107.99m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 10-Dec-2025

Time Volume / Share Price
16:21 35 @ 680.00p
16:21 200 @ 700.00p
12:45 3 @ 710.00p
12:44 31 @ 710.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page